4
Changes in Ownership
Organogenesis Holdings Inc. Filed Acc 0001062993-24-004313
Chief Commercial Officer acquired 173,469 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grow Brian Chief Commercial Officer | 2024-02-21 | Grant or award | +173,469 | 522,786 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Grow Brian Chief Commercial Officer | 2024-02-21 | Grant or award · Stock Option (Right to Buy) | +313,636 | 313,636 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…